The research, co-led by Parc Taulí, studies how infection with the SARS-CoV-2 virus and changes in the hospital environment caused by the pandemic influenced the resistance and virulence of the bacte...
Read moreDurante el primer año de la pandemia de COVID-19, la mortalidad afectó de forma especialmente intensa a los pacientes mayores de 70 años, en un contexto en el que todavía no se disponía de vacuna...
Read morePor un lado, se han diseñado pequeños péptidos capaces de bloquear proteínas clave del virus implicadas en la replicación de su material genético y en la evasión del sistema inmunitario y, por ...
Read moreIn first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission rate (CRc) of 93% (with 79% CR), and an estimated 12-mon...
Read moreOryzon Genomics a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating iadadems...
Read moreA prospective study of more than 1,000 people vaccinated with TAK-003 in Catalonia found no serious adverse events and provides new evidence on the vaccine’s short-term safety in travellers
Read moreIn first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demo...
Read moreLa propuesta ha superado favorablemente todas las fases de la evaluación internacional, incluida la revisión por parte del Independent Evaluation Panel (IEP)
Read moreResearchers from ICO and IDIBELL have developed a simple model based on health questionnaires that could help identify people who are more likely to suffer from the disease before symptoms appear.
Read moreThe study was based on data from more than 250,000 women from 7 European countries collected over 14 years, analysing in detail the intake of these compounds and their relationship with different subt...
Read moreUn estudio del Instituto de Biomedicina de Valencia (IBV-CSIC) desvela alteraciones en el ADN de la bacteria ‘Mycobacterium tuberculosis’ que pasaban desapercibidas para las técnicas convencional...
Read more